Hypohidrotic ectodermal dysplasia with immune deficiency

Add links
From Wikipedia, the free encyclopedia
Hypohidrotic ectodermal dysplasia with immune deficiency
This condition is usually inherited in an X-linked recessive manner
SpecialtyMedical genetics

Hypohidrotic/anhidrotic ectodermal dysplasia with immune deficiency is a rare genetic condition characterized by a combination of the features of ectodermal dysplasia alongside immunodeficiency.

Signs and symptoms[edit]

Individuals with this condition typically exhibit a milder version of the symptoms that patients with another type of ectodermal dysplasia would display, these include:[1][2]

  • Sparse to no hair throughout the body (hypotrichosis/atrichia)
  • Dysplastic (malformed), hypoplastic (underdeveloped), or aplastic (missing) teeth
  • Little to no ability to sweat (hypo/anhidrosis)
  • Frontal bossing (prominence of the forehead)
  • Wrinkling under the eyes
  • Periorbital hyperpigmentation

These symptoms are accompanied by an immunodeficiency that affects the entire body and impairs the body's antibody response (especially that to polysaccharides). It causes various complications in and on itself, alongside a failure to thrive.[2]

Complications[edit]

Most complications exhibited by people with the condition are associated with the immunodeficiency that is characteristic of it. These complications include:

  • Hypogammaglobulinemia[2]
  • Recurrent infections (most of which are severe)[2][3]
    • Recurrent respiratory tract infections
      • Recurrent bronchiectasis
    • Recurrent digestive tract infections
    • Recurrent skin infections
  • Increased susceptibility to autoimmune disorders[4]
  • Impairments of natural killer cell cytotoxicity.[4]

Early death (usually in infancy) can occur as a complication in some cases.[5]

Genetics[edit]

This condition has two known genetic causes, and both genetic causes have different inheritance patterns:[6][7]

IKBKG[edit]

The NF-kappa-B essential modulator protein, produced by the IKBKG gene

The first cause (and most common out of the 2) is a genetic mutation in the IKBKG gene, located in the X chromosome at the q28 locus.[1]

The protein that is encoded by this gene serves as the regulatory subunit of the inhibitor of IκB kinase (IKK) complex, it helps activate NF-κB, which in turn activates multiple genes that play an important role in inflammation, immunity, cell survival, and other pathways.[8][9][10]

The mutation involved in this disorder significantly alters the function of the NF-kappa-B essential modulator protein, this impairs the protein's ability of regulating itself. It's this impairment that causes the interruption of various signaling pathways within the cells that form ectodermal tissue and the immune cells, this disruption causes the abnormal/poor development of ectodermal tissues and the immunodeficiency characteristic of this condition. Whether or not the condition is severe is determined by the amount of appropriate function the protein can perform on itself,[11] loss-of-function mutations of the gene can cause antenatal male lethality.[12]

This mutation is inherited following an X-linked recessive pattern, which means that for a person to exhibit the symptoms of the condition, they must have inherited a copy of the malfunctioning gene in all of their copies of the X chromosome. For this reason, the condition affects males more than it affects females, this is due to the fact that females carry two copies of the X chromosome, one of which may carry a healthy copy of the gene, while men on the other hand carry only one copy of the X chromosome, the other copy being the Y chromosome they inherited from their fathers; if they inherit the malfunctioning copy of the gene in their only X chromosome, they will automatically be homozygous for the disease and thus they will have the symptoms of the syndrome. Since males inherit one copy of the X chromosome from their mother and one copy of the Y chromosome from their father, the condition can only be inherited maternally. Females who do end up inheriting a malfunctioning copy of the gene will be heterozygous, which in turn will leave them as unaffected carriers.[13]

NFKBIA[edit]

The nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha protein, produced by the NKFBIA gene

The second cause (and least common out of the 2) is a genetic mutation in the NFKBIA gene, located in chromosome 14 at the q13.2 locus.[14]

The protein that is encoded by this gene inhibits the NF-κB transcription factor through the masking of nuclear localization signals from NF-κB transcription factor proteins, this process keeps them in an inactive state in the cytoplasm. It also helps blocking the NF-κB transcription factors protein's ability of binding itself to DNA. The latter process is essential for the protein's appropriate functioning.[15]

The way this mutation works is almost exactly the same as the way of the previously mentioned mutation works, however, a key difference between this mutation and the aforementioned one is that it is inherited following an autosomal dominant manner.[16]

Autosomal dominant inheritance means that for a condition to exhibit itself on a person, said person needs to have at least one copy of the mutated version of the gene, this copy had to either appear spontaneously (a phenomenon known as de novo mutation) or it had to be inherited from one of the person's parents.[17]

Diagnosis[edit]

This condition can be diagnosed through methods such as genetic testing (encompassing terms such as whole exome sequencing, Sanger sequencing, etc.), routine laboratory tests, and physical examination.[2][8][18][19]

Treatment[edit]

Bone marrow transplants have been reported as being both successful and unsuccessful at managing the symptoms caused by the disorder.[20] The latter (unsuccessful transplants) are usually not efficient at treating symptoms due to the transplants themselves causing post-surgical complications and, in some cases, death.

Prevalence[edit]

The X-linked recessive form of HHED-I has an estimated incidence of about 1 out of every 250,000 live births.[2]

The autosomal dominant form of HHED-I only has 13 to 27 cases reported in medical literature as of September 2022 (source: OMIM).[21][1][2]

History[edit]

This condition was first discovered in 2000, by Zonana et al, when they described various male individuals belonging to 4 unrelated families. Said individuals showed signs of ectodermal dysplasia (with symptoms such as teeth dysplasia, poor ability of sweating, and, in some cases, sparse hair) and had presented to various doctor visits since the early years of their life due to recurrent bacterial infections and their complications. Laboratory studies showed increased levels of IgM, low levels of IgA, equally low levels of IgG, and dysgammaglobulinemia. Tests done on their immunological responses showed an absent antibody response to pneumonoccal infections, while their body's response to tetanus was normal. Genetic tests done on the males revealed a loss-of-function mutation in exon 10 of their IKBKG gene, the mutation was present in a hemizygous state. The most severely affected patients were 2 brothers from the fourth family in the study, who had died at the age of 3 years old after a strong viral infection which their body got overwhelmed with.[22]

The autosomal dominant variant of this condition was discovered in 2003 by Courtois et al, their patient was a 7-year-old male child born to healthy, unrelated non-consanguineous parents. He had infancy-onset chronic diarrhea, hepatosplenomegaly, failure to thrive, recurrent bronchopnemonitis, presence of moderately sparse hair of the scalp, conical teeth, and rough dry skin. After having genetic testing done on him, it was found that he carried a missense gain-of-function mutation in serine 32 of his NFKBIA gene, the mutation was present in a heterozygous state. He had a successful bone marrow transplant, with the bone marrow having been donated by his (unaffected) sister, and as total donor chimerism set in his blood cells, his body's immune responses improved in quality.[23]

References[edit]

  1. ^ a b c "Anhidrotic ectodermal dysplasia with immune deficiency: MedlinePlus Genetics". medlineplus.gov. Archived from the original on 2021-11-01. Retrieved 2022-09-24.
  2. ^ a b c d e f g RESERVED, INSERM US14-- ALL RIGHTS. "Orphanet: Hypohidrotic ectodermal dysplasia with immunodeficiency". www.orpha.net. Archived from the original on 2017-07-30. Retrieved 2022-09-24.{{cite web}}: CS1 maint: numeric names: authors list (link)
  3. ^ Döffinger, R.; Smahi, A.; Bessia, C.; Geissmann, F.; Feinberg, J.; Durandy, A.; Bodemer, C.; Kenwrick, S.; Dupuis-Girod, S.; Blanche, S.; Wood, P.; Rabia, S. H.; Headon, D. J.; Overbeek, P. A.; Le Deist, F. (March 2001). "X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling". Nature Genetics. 27 (3): 277–285. doi:10.1038/85837. ISSN 1061-4036. PMID 11242109. S2CID 24898789.
  4. ^ a b Kawai, Tomoki; Nishikomori, Ryuta; Heike, Toshio (2012-01-01). "Diagnosis and Treatment in Anhidrotic Ectodermal Dysplasia with Immunodeficiency". Allergology International. 61 (2): 207–217. doi:10.2332/allergolint.12-RAI-0446. ISSN 1323-8930. PMID 22635013.
  5. ^ Johnston, Alicia M.; Niemela, Julie; Rosenzweig, Sergio D.; Fried, Ari J.; Delmonte, Ottavia Maria; Fleisher, Thomas A.; Kuehn, Hyesun (August 2016). "A Novel Mutation in IKBKG/NEMO Leads to Ectodermal Dysplasia with Severe Immunodeficiency (EDA-ID)". Journal of Clinical Immunology. 36 (6): 541–543. doi:10.1007/s10875-016-0309-y. ISSN 1573-2592. PMC 5007618. PMID 27368913.
  6. ^ "Hypohidrotic ectodermal dysplasia with immune deficiency - About the Disease - Genetic and Rare Diseases Information Center". rarediseases.info.nih.gov. Archived from the original on 2022-05-01. Retrieved 2022-09-24.
  7. ^ "X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival". ashpublications.org. June 2014. Archived from the original on 2022-01-21. Retrieved 2022-09-24.
  8. ^ a b Mancini, Anthony J.; Lawley, Leslie P.; Uzel, Gulbu (2008-03-01). "X-Linked Ectodermal Dysplasia With Immunodeficiency Caused by NEMO Mutation: Early Recognition and Diagnosis". Archives of Dermatology. 144 (3): 342–346. doi:10.1001/archderm.144.3.342. ISSN 0003-987X. PMID 18347290.
  9. ^ Carrol, E. D.; Gennery, A. R.; Flood, T. J.; Spickett, G. P.; Abinun, M. (2003-04-01). "Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO". Archives of Disease in Childhood. 88 (4): 340–341. doi:10.1136/adc.88.4.340. ISSN 0003-9888. PMC 1719512. PMID 12651765. Archived from the original on 2018-06-03. Retrieved 2022-09-24.
  10. ^ Keller, Michael D.; Petersen, Maureen; Ong, Peck; Church, Joseph; Risma, Kimberly; Burham, Jon; Jain, Ashish; Stiehm, E. Richard; Hanson, Eric P.; Uzel, Gulbu; Deardorff, Matthew A.; Orange, Jordan S. (2011-11-08). "Hypohidrotic Ectodermal Dysplasia and Immunodeficiency with Coincident NEMO and EDA Mutations". Frontiers in Immunology. 2: 61. doi:10.3389/fimmu.2011.00061. ISSN 1664-3224. PMC 3341983. PMID 22566850.
  11. ^ "IKBKG gene: MedlinePlus Genetics". medlineplus.gov. Archived from the original on 2021-10-19. Retrieved 2022-09-24.
  12. ^ Döffinger, Rainer; Smahi, Asma; Bessia, Christine; Geissmann, Frédéric; Feinberg, Jacqueline; Durandy, Anne; Bodemer, Christine; Kenwrick, Sue; Dupuis-Girod, Sophie; Blanche, Stéphane; Wood, Philip; Rabia, Smail Hadj; Headon, Denis J.; Overbeek, Paul A.; Le Deist, Françoise (March 2001). "X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling". Nature Genetics. 27 (3): 277–285. doi:10.1038/85837. ISSN 1546-1718. PMID 11242109. S2CID 24898789. Archived from the original on 2022-06-16. Retrieved 2022-09-24.
  13. ^ "X-linked recessive inheritance". www.cancer.gov. 2011-02-02. Retrieved 2022-09-24.
  14. ^ "Hypohidrotic Ectodermal Dysplasia - an overview | ScienceDirect Topics". www.sciencedirect.com. Retrieved 2022-09-24.
  15. ^ Jacobs, Marc D.; Harrison, Stephen C. (1998-12-11). "Structure of an IκBα/NF-κB Complex". Cell. 95 (6): 749–758. doi:10.1016/S0092-8674(00)81698-0. ISSN 0092-8674. PMID 9865693. S2CID 7003353.
  16. ^ "NFKBIA gene: MedlinePlus Genetics". medlineplus.gov. Archived from the original on 2021-04-20. Retrieved 2022-09-24.
  17. ^ "autosomal dominant inheritance". www.cancer.gov. 2011-02-02. Retrieved 2022-09-24.
  18. ^ Orange, Jordan S.; Brodeur, Scott R.; Jain, Ashish; Bonilla, Francisco A.; Schneider, Lynda C.; Kretschmer, Roberto; Nurko, Samuel; Rasmussen, Wendy L.; Köhler, Julia R.; Gellis, Stephen E.; Ferguson, Betsy M.; Strominger, Jack L.; Zonana, Jonathan; Ramesh, Narayanaswamy; Ballas, Zuhair K. (June 2002). "Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations". The Journal of Clinical Investigation. 109 (11): 1501–1509. doi:10.1172/JCI14858. ISSN 0021-9738. PMC 150995. PMID 12045264.
  19. ^ Janssen, Riny; van Wengen, Annelies; Hoeve, Marieke A.; ten Dam, Monique; van der Burg, Miriam; van Dongen, Jacques; van de Vosse, Esther; van Tol, Maarten; Bredius, Robbert; Ottenhoff, Tom H.; Weemaes, Corry; van Dissel, Jaap T.; Lankester, Arjan (2004-09-06). "The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes". The Journal of Experimental Medicine. 200 (5): 559–568. doi:10.1084/jem.20040773. ISSN 0022-1007. PMC 2212739. PMID 15337789.
  20. ^ Pai, Sung-Yun; Levy, Ofer; Jabara, Haifa H.; Glickman, Jonathan N.; Stoler-Barak, Liat; Sachs, Jessica; Nurko, Samuel; Orange, Jordan S.; Geha, Raif S. (December 2008). "Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency". The Journal of Allergy and Clinical Immunology. 122 (6): 1113–1118.e1. doi:10.1016/j.jaci.2008.08.026. ISSN 1097-6825. PMC 6141239. PMID 18851875.
  21. ^ "Entry - #612132 - ECTODERMAL DYSPLASIA AND IMMUNODEFICIENCY 2; EDAID2 - OMIM". omim.org. Archived from the original on 2022-08-14. Retrieved 2022-09-24.
  22. ^ Zonana, J.; Elder, M. E.; Schneider, L. C.; Orlow, S. J.; Moss, C.; Golabi, M.; Shapira, S. K.; Farndon, P. A.; Wara, D. W.; Emmal, S. A.; Ferguson, B. M. (December 2000). "A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)". American Journal of Human Genetics. 67 (6): 1555–1562. doi:10.1086/316914. ISSN 0002-9297. PMC 1287930. PMID 11047757.
  23. ^ Courtois, Gilles; Smahi, Asma; Reichenbach, Janine; Döffinger, Rainer; Cancrini, Caterina; Bonnet, Marion; Puel, Anne; Chable-Bessia, Christine; Yamaoka, Shoji; Feinberg, Jacqueline; Dupuis-Girod, Sophie; Bodemer, Christine; Livadiotti, Susanna; Novelli, Francesco; Rossi, Paolo (October 2003). "A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency". The Journal of Clinical Investigation. 112 (7): 1108–1115. doi:10.1172/JCI18714. ISSN 0021-9738. PMC 198529. PMID 14523047.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Hypohidrotic_ectodermal_dysplasia_with_immune_deficiency&oldid=1182164461"